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Study Design and Setting: This is a hypothesis-generating discussion article.
Results: An additivity assumption underlying conventional thinking in trial design and analysis is problematic in behavioral interven-
tion trials. Postrandomization sources of bias are somewhat better known within the clinical epidemiological and trials literatures. Neglect
of attention to possible research participation effects means that unintended participant behavior change stemming from artifacts of the
research process has unknown potential to bias estimates of behavioral intervention effects.
Conclusion: Studies are needed to evaluate how research participation effects are introduced, and we make suggestions for how
research in this area may be taken forward, including how these issues may be addressed in the design and conduct of trials. It is proposed
that attention to possible research participation effects can improve the design of trials evaluating behavioral and other interventions and
inform the interpretation of existing evidence.  2014 The Authors. Published by Elsevier Inc.
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1. Introduction we currently believe, and it has been suggested that research
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as the most rigorous research designs for the evaluation of
the effects of interventions. Behavioral intervention trials
are studies in which the primary purpose is to evaluate at-
tempts to influence behavior or the consequences of any re-
sultant behavior change. They are important to public health
as lifestyle behavioral risk factors contribute strongly to
a wide range of health problems [1]. Data from our best be-
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Open access under Cparticipation may account for more observed change than
evaluated interventions [2]. It has long been known that par-
ticipants may react in unintended ways to being studied and
this may lead to change [3]. It is suggested that this entails
largely overlooked potential for bias in behavioral interven-
tion trials. Valid inferences about the true effects of behav-
ioral interventions are hampered by our inability to
identify and rule out alternative explanations for behavior
change. These concerns have much wider relevance as al-
most all trials and other types of human research depend
on the cooperation of their participants, which may be un-
wittingly influenced by the way studies are conducted.2. Assessment and other aspects of research
participation may change behavior
Taking part in trials typically involves both recruitment
and baseline assessment activities before randomization,
and subsequently exposure to study conditions and assess-
ment at follow-up. Any or all of these research activitiesC BY license. 
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 An additivity assumption underlying conventional
trial design and analysis is problematic in behav-
ioral intervention trials.
 Pre and postrandomization research participation
effects may interact with evaluated interventions.
 Randomization does not fully prevent the introduc-
tion of bias via these mechanisms.
 New conceptual and empirical work is needed to
better understand these problems.
 Research artifacts in other types of trials should
also be amenable to control.may influence participant cognitions, emotions, and behav-
ior. Formally signing a consent form, for example, may lead
to or strengthen commitment to behavior change. Questions
answered for research assessment purposes may stimulate
new thinking about the behavior, which also may be a pre-
lude to action [4,5].
It is difficult to point to any well-established coherent
body of literature investigating these issues. There exist,
however, somewhat disparate strands of relevant research,
and thinking about research, which relate to different parts
of the research process being investigated, or have their or-
igins in specific disciplines or research contexts, or are con-
cerned with specific methodological problems in research.
For example, assessment reactivity effects in trials of brief
alcohol interventions jeopardize the safety of inferences
made because although reactivity effects may be small,
the effects of the interventions being evaluated are also
small [6]. In this field, because assessment is an integral
component of the brief interventions being evaluated, re-
search assessments produce contamination in the form of
unwitting exposure of the control group to intervention
content [7].
There is a plethora of labels and constructs that have been
developed to describe and study similar phenomena. For
example, within health psychology, assessment reactivity is
conceptualized as ‘‘mere measurement,’’ ‘‘question-behav-
ior,’’ or ‘‘self-generated validity’’ effects [4,5,8]. Synthesiz-
ing this type of literature is challenging as many findings
have been generated incidentally to the main purposes of
the research being undertaken. The idea that being assessed
itself influences behavior has, however, been established
in the literature for approximately one 100 years [3]. The
Hawthorne effect, usually taken to mean that monitoring of
a behavior for research purposes changes performance of that
behavior, is approximately 60 years old [9]. This is probably
the most recognizable term used to describe the effects of
being assessed across disciplines [10e12].Around the same time, an alteration to basic experimental
design, the Solomon four-group design, was developed to
allow quantification of the size of baseline assessment effects
and to control for them [3]. Campbell [13] subsequently
proposed that assessments may interact with interventions
to either strengthen or weaken observed effects, thus produc-
ing biased estimates of effects. The construct of ‘‘demand
characteristics’’ [14,15] was subsequently introduced in
psychology, referring to the ways in which study participants
adjust their responses according to their perceptions of the
implicit preferences or expectations of researchers, to be
‘‘good subjects’’ [16].
Four recent systematic reviews summarize and evaluate
empirical data on assessment reactivity in brief alcohol in-
tervention trials [7], the Hawthorne effect [17], applications
of Solomon four-group designs [18], and demand character-
istic studies in nonlaboratory settings [19]. Collectively,
these reviews demonstrate that being assessed can impact
on behaviors, with small effects usually having been identi-
fied, albeit inconsistently, on both self-reported and objec-
tively ascertained outcomes. These are due to being
interviewed, completing questionnaires, or being observed.
These four reviews do not, however, provide strong evi-
dence of assessment effects as there were substantial weak-
nesses in the primary studies. Strong and consistent themes
to emerge from these studies are the need for a new gener-
ation of primary studies dedicated to estimate the size of as-
sessment and other possible research participation effects,
and the mechanisms of their production, and the circum-
stances in which they occur.3. Overlooked prerandomization sources of bias in
behavioral intervention trials
The example provided in Box 1 suggests that in such
cases, reliable effect estimation has been precluded and thus
that randomization has not protected against some form of
bias. The reason for this is the violation of a key assumption
in conventional trial design and analysis on which the
capacity of randomization to prevent bias depends. This is
the additivity assumption [20] that the effects of the inter-
vention being evaluated are independent of any possible
prerandomization effects of research participation. In simple
terms, this implies that it does not matter whether assess-
ment changes behavior or participants react to some other
aspect of being researched before randomization because
with sufficiently large numbers, randomization guarantees
between-group equivalence and ensures that randomized
groups differ only in outcomes as a function of the interven-
tion being studied.
Attention has previously been drawn to this additivity as-
sumption in pharmacological trials in mental health [20], al-
though its implications are rarely considered more widely.
This assumption is untenable in behavioral intervention tri-
als, most obviously where the research and intervention
Box 1 An hypothetical example using smoking
cessation data [57]
The most effective smoking cessation behavioral
interventions such as high-intensity counseling result
in a true cessation rate of approximately 22%. Recruit-
ment and assessment in trials can provide a stimulus to
quit, and reinforcement of this decision, for those
who are most ready, willing, and able to successfully
change this behavior. This yields an approximately
11% cessation rate in control conditions in these
same studies. This exceeds both the cessation rates
of approximately 3% and 6% seen in unscreened
and screened smokers, respectively. In an RCT, only
a further 11% of those allocated to intervention will
be responding to the evaluated intervention itself. In
this situation, outcomes in the trial will be 22% for
the intervention group compared with 11% for the
control group, an 11% difference, which is a biased
estimate of the true effect.
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outcomes. In addition to completing questionnaires, keeping
diaries, regular weighing, and using pedometers for both
research and intervention purposes, there are other less
obvious similarities. For example, making interpersonal
declarations of commitment to change, as is often done in
providing formal consent, is also a component of many ef-
fective behavioral interventions (eg, Ref. [21]). Indeed, self-
monitoring and self-regulatory mechanisms through which
the research process may influence participants are those
same mechanisms that are targeted by behavioral interven-
tions [8,22]. In such scenarios, prerandomization effects
cannot be separated from impact on the postrandomization
behavior of both intervention and control groups, and biased
estimates of effects occur because of this interaction
[13,18]. This same issue applies also to drug and placebo
effects in pharmacological trials, in which both may confer
benefit [20].
Elaborating on Campbell [13], intervention effect esti-
mates could be erroneously diluted when there may be lim-
ited capacity for behavior change, which is partially
accounted for by prerandomization reactivity, as in the
example provided in Box 1. Motivation to change behavior
can be thought of as existing on a continuum, with some
people more ready to change and others less so [23]. The
stimulus provided by research participation may provide
sufficient motivation for some people to change their be-
havior. It is reasonable to suppose that other aspects of
the research process could also influence participant cogni-
tion, affect, and behavior. This stimulus entails a ceiling ef-
fect, and this is likely to be common for preexisting
behaviors where participants have thought about the behav-
ior before, have made previous attempts at change, and/orare in a state of contemplation about behavior change
[18]. Smoking, sedentary lifestyle, overeating, heavy drink-
ing, or other well-established behaviors about which there
are obvious grounds for concern are probably good exam-
ples of this situation in which trials may underestimate
the true effects of interventions.
We also offer the basis for hypotheses about how inter-
vention effects may be artifactually inflated in trials in
which observed effects of the evaluated intervention are
contingent on prior preparation provided by the research
process. This scenario is most obviously plausible in eval-
uations of interventions in which reflection on the behavior
has been absent previously and is promoted by research
participation, thus helping to prepare people for change.
This produces a synergistic effect, which may be strongest
for the uptake of new behaviors, particularly when some
degree of planning for the enactment of the behavior is
required [18]. One study included within the Solomon
four-group systematic review provided an example of this,
where adolescents’ completion of a lengthy questionnaire
on sexual behavior influenced receptivity to intervention
and subsequent condom use outcome [24]. This may be
more likely when participants are proactively recruited
for intervention on a particular behavior rather than among
help seekers or other more active volunteers. It also may be
more applicable to health protection rather than existing
health-compromising behaviors and more likely in some
populations than in others. For example, children and
young people may have devoted less time to reflect on
some of their behaviors than other populations. It is impor-
tant to note that the mere existence of any of these interac-
tion effects is sufficient to undermine internal validity
because they bias intervention effect estimates.4. Overlooked postrandomization sources of bias in
behavioral intervention trials
The problems just described are analogous to the ran-
domization barrier being somewhat porous to the introduc-
tion of bias from prerandomization research participation
effects. To the extent that the process or outcome of ran-
domization themselves exert direct effects on behavior,
these will constitute further sources of bias. Cook and
Campbell [25] described the uncertainty inherent in ran-
domization as potentially generating apprehension that
can influence outcomes. This is thus another prerandomiza-
tion source of bias. Reactions to the outcome of randomiza-
tion, however, are by definition postrandomization. There
may be deleterious effects on control group participants
when they give up attempts to change, labeled as ‘‘resentful
demoralization’’ [25]. Cook and Campbell [25] also used
the term ‘‘compensatory rivalry’’ to refer to enhanced ef-
forts at change by securing interventions outside the con-
text of the trial. Such responses are contingent on
disappointment at the outcome of randomization. This
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can have preferences for allocation within trials [26], and
these preferences can have far reaching consequences,
including impacting on trial outcomes [27].
For these reasons, patient preference designs [28] have
been developed to avoid randomizing participants with
strong allocation preferences to study conditions that would
be disappointing. Similarly, Zelen designs [29e31] have
also been developed for situations in which seeking consent
for randomization may invoke unwanted responses. The use
of both designs in many areas beyond the present focus on
behavioral intervention trials [32,33] further indicates that
these concerns are applicable to experimenting with people
in other contexts. We suggest that the underlying nature of
the problems posed by expectations and disappointment
(apart from in relation to placebo effects [34e36]) and their
implications for valid inferences in trials are not widely
appreciated, although an article by Colagiuiri [37] is a note-
worthy exception. There are valuable qualitative studies
illustrating, for example, the dynamic nature of allocation
preferences in trials [38], although there are few quantita-
tive studies, other than the patient preference trials them-
selves. In our perspective, preferences arise out of the
interaction of the participant and the research process. Par-
ticipants may bring not only allocation preferences but also
a wide array of hopes and concerns, motivations and uncer-
tainties, and other cognitions and emotions to their involve-
ment in trials that are more or less intrinsic to
experimenting with people. This situation calls for careful
deliberation in study design and vigilance for the intrusion
of significant biases arising from these interactions.
Another possible source of bias after randomization to
which little attention has previously been given is when
there are seemingly trivial differences in the follow-up as-
sessments completed by each group. This situation could
arise, for example, when the intervention group is required
to provide feedback data on the intervention. This could
cause participants to reflect on their behavior differentially
between groups and introduce bias to subsequent follow-
up assessments. This constitutes an example that fits well
with current thinking about performance bias [39,40], where
seemingly minor differences in research conditions contrib-
ute to different outcomes. This construct is useful because it
directs attention to what is done to or with study partici-
pants. In addition to these examples we have provided, other
postrandomization sources of bias such as those associated
with compliance to allocated interventions are much better
understood, and consequently, there are analytical strategies
developed for dealing with them [41,42]. For postrandom-
ization sources of bias, simple main effects on later out-
comes and more complex interaction effects introduce bias.
Even when there are no differences at all in the content
of follow-up data collection or other postrandomization
study procedures, the intervention group being reminded
of intervention content, and it being thus reinforced, can
be a means by which bias is introduced. This situation isnot well captured by the existing definition of performance
bias as the bias originates not in any differences in how par-
ticipants are treated by the research study [39] but in how
participants respond differently, specifically as a result of
their allocation. It is a moot point how well the construct
of performance bias captures this type of problem.5. The need for new research on these sources of bias
We propose that hypotheses concerning the main effects
of prerandomization artifacts warrant testing in two-arm
experimental studies as precursors to more complex evalu-
ations of interaction effects in four-arm studies. For exam-
ple, if assessments do not have main effects, their possible
interactions with randomization outcomes are much less
promising targets for investigation. For two-arm experi-
ments, manipulations of the process of informed consent,
for example, knowing that randomization will occur or
what is the particular behavior under investigation [43],
provide examples of possible targets for study.
Interactions between recruitment or assessment effects
and the outcome of randomization produce bias in be-
havioral intervention trials, as do the main effects of
postrandomization artifacts such as responses to either
earlier follow-up assessments or randomization outcome
other than precisely as intended by the design of the inter-
ventionecontrol contrast [44]. The basic design structure
of the tests of these hypotheses is straightforward. In the
four-arm trial in the manner of the factorial or Solomon
four-group design, which randomizes to intervention or as-
sessment exposure, both or neither, content does not need
to be restricted to investigation of assessment effects. For
example, individual informed consent could be experimen-
tally manipulated in this way, with the procedure either
omitted or altered in a study in which intervention expo-
sure is also randomized. The ethical challenges involved
are arguably more complex than the study design consider-
ations, and we have elaborated elsewhere justifications for
the use of deception in relation to both methodological and
substantive evaluation studies of brief alcohol intervention
effectiveness [45].
We suggest that specifying the optimal research condi-
tions in which these types of studies should be undertaken
is more difficult to do, however, than producing the basic
structure of the study designs. Which behaviors, popula-
tions, settings, and interventions are most promising for
investigation? Some suggestions have been made here.
Eliciting the experiences and views of researchers [46]
and securing their collaboration in doing this research will
help identify priorities for such studies, as will facilitating
direct contributions from research participants themselves.
Research participation effects may be implicated in
other more well-known threats to valid inference [40]. They
may interact with attrition bias to produce differential
follow-up rates between study groups. Similarly, if
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cause of their allocation, this can lead to detection bias.
Behavioral intervention trials often necessarily rely on
self-reported behavioral data, and such studies may be es-
pecially vulnerable to these effects [47]. In both examples
provided here, detailed scrutiny of the literature on these
better known forms of biases [48] may be useful to under-
stand the potential for the types of research participation ef-
fects considered here to produce bias. Although blinding
may be used to protect against various forms of bias, it
may be less available and thus less useful in behavioral
intervention trials than elsewhere [49].
History demonstrates disappointingly slow progress in
thinking about the nature of the problems described here
and in successfully studying them [19]. A conceptual
framework (eg, Ref. [50]) will need to be built over time,
probably informed by both qualitative and quantitative
data, and evaluation of the difficult ethical issues involved
in deception can be informed by dedicated methodological
studies (see Ref. [51]). Further work on this subject may
well require the development of new terminology to over-
come existing disciplinary and research topic barriers.Box 2 Trial design considerations
1. Incorporate examination of potential for research
participation effects in pilot investigations of all
trial procedures in which there may be any
concern.
2. Ask participants whether and how research partic-
ipation affects them in formal qualitative and
quantitative studies nested within trials.
3. Collect and analyze data on routine and seemingly
unremarkable aspects of the research process, on
both formal and informal contacts.
4. Minimize interpersonal contacts and be as unob-
trusive as possible.
5. Be careful with research assessments obtained
directly from participants.
6. Consider the possible benefits of baseline data
collection in relation to the possible risk of bias.
7. Undertake randomized substudies within trials to
measure potential research artifacts.
8. Explore all available content options for blinding.
9. Evaluate the use of blinding and deception, from
both ethical and methodological perspectives.
10. Ensure no aspects of trial design and conduct
interfere with the precise experimental contrast
that answering your research question demands.Existing constructs such as the Hawthorne effect and de-
mand characteristics lack specificity and permit too many
meanings to be useful when used alone.
Notwithstanding these challenges, the authors contend
that the need for this research is no longer ignorable in re-
lation to behavioral intervention trials. It is not clear how
important attention to these issues is in other types of trials,
and this question merits consideration. Behavioral interven-
tion trials that are sensitive to the issues raised here may
have interesting design characteristics. The AMADEUS-1
trial, for example, blinded all participants to involvement
in the trial at all stages of the study and used a no-
contact control group for comparison with intervention
groups in receipt of routine practice [52]. This is an unusual
example of an unobtrusive evaluation of service provision
specifically designed to avoid or minimize research partic-
ipation effects. Trial outcomes further demonstrated the
substance of these concerns, where assessment-only had
very similar effects to assessment and feedback compared
with no contact [53]. Preliminary suggestions applicable
to the design and conduct of more conventional trials are
offered in Box 2.6. Conclusions
There has been no attempt here to produce a fully com-
prehensive guide to possible research participation effects
in behavioral intervention trials. For example, we should
expect that reasons for participation in these types of stud-
ies will be important to the existence and the nature of any
research participation effects [54]. Routine practices such
as paying people to participate should be expected to
have some impact on both these reasons for participation
and possibly also their subsequent relationship with the
research [55]. We suggest that the construct of research
participation effects can provide a useful basis for more
comprehensive evaluations of the possible problems dis-
cussed here.
There are also obvious solutions to some of these possible
problems, by omitting when possible the aspect of study con-
duct believed to be responsible. These problems are very
likely to be widely amenable to elimination by design, or sta-
tistical control if not, as they are artifacts of the decisions
made by researchers. When a possible source of such bias
is identified and it is not clear how much of a threat to val-
idity may be entailed, the likely benefit of the data gained
with this design decision must be considered in relation to
the risk of bias. This pragmatic costdbenefit appraisal
may resemble how research decisions are routinely made.
The thinking presented here on possible problems aris-
ing from experimenting with people in behavioral interven-
tion and other types of trials does not provide reasons to
abandon them. As Hollon [56] has remarked ‘‘to paraphrase
Churchill on democracy, RCTs are fallible and far from
perfect; the only good thing that we can say about them
252 J. McCambridge et al. / Journal of Clinical Epidemiology 67 (2014) 247e253is that they are better than the alternatives.’’ We suggest that
attention to possible research participation effects provides
a means by which RCTs can be improved in delivering less
biased estimates of behavioral and other intervention ef-
fects, if and when this is needed.References
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